Table 1.
Characteristic of Respondents and Nonrespondents.
| Characteristics | Respondents (N = 603) | Nonrespondents (N = 1189) |
|---|---|---|
| Age, years, mean (SD) | 63.5 (11.0) | 61.1 (12.0) |
| Sex, female, n (%) | 372 (61.7) | 657 (55.3) |
| Race, white, n (%) | 476 (78.9) | 809 (68.0) |
| Ethnicity, non-Hispanic, n (%) | 591 (98.0) | 1141 (96.0) |
| Cancer type, n (%) | ||
| Breast | 283 (46.9) | 468 (39.4) |
| Prostate | 164 (27.2) | 331 (27.8) |
| Colorectal | 87 (14.4) | 221 (18.6) |
| Lung | 69 (11.4) | 169 (14.2) |
| Cancer stage,a n (%) | ||
| 0-1 | 278 (46.4) | 463 (39.5) |
| 2 | 214 (35.7) | 450 (38.4) |
| 3 | 68 (11.4) | 158 (13.5) |
| 4 | 39 (6.5) | 102 (8.7) |
a
Of all surveyed participants (respondents and nonrespondents), 160 were cancer stage “0” and 581 patients were stage “1.” Among 160 stage “0” participants, 144 (90%) had breast cancer; among 581 stage “1” patients, 259 (45%) had breast cancer. Nine patients’ cancer stage was unknown.